Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria

NCT04708483 is registered in ClinicalTrials.gov with Hyperfusion as lead sponsor.

NCT NCT04708483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria
Lead sponsor
Hyperfusion
Phase
Not applicable
Overall status
Unknown status
Start date
January 7, 2021
Completion date
December 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer liver, cancer, lung, metastatic liver cancer, metastatic lung cancer, perfusion computed tomography target lesion